BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 9466088)

  • 1. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.
    Mourilhe P; Stokes PE
    Drug Saf; 1998 Jan; 18(1):57-82. PubMed ID: 9466088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine tenth anniversary update: the progress continues.
    Stokes PE; Holtz A
    Clin Ther; 1997; 19(5):1135-250. PubMed ID: 9385500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia.
    Ravindran AV; Bialik RJ; Lapierre YD
    Can J Psychiatry; 1994 Feb; 39(1):21-6. PubMed ID: 8193995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of early-onset depression. Update and new directions.
    Martin A; Kaufman J; Charney D
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):135-57. PubMed ID: 10674194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin-reuptake inhibitors: an update.
    Masand PS; Gupta S
    Harv Rev Psychiatry; 1999; 7(2):69-84. PubMed ID: 10471245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.